Biocompatible blood pool MRI contrast agents based on hyaluronan

Wenlian Zhu, Dmitri Artemov

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Biocompatible gadolinium blood pool contrast agents based on a biopolymer, hyaluronan, were investigated for magnetic resonance angiography application. Hyaluronan, a non-sulfated linear glucosaminoglycan composed of 2000-25,000 repeating disaccharide subunits of D-glucuronic acid and N-acetylglucosamine with molecular weight up to 20 MDa, is a major component of the extracellular matrix. Two gadolinium contrast agents based on 16 and 74kDa hyaluronan were synthesized, both with R1 relaxivity around 5mM-1s-1 per gadolinium at 9.4 T at 25°C. These two hyaluronan based agents show significant enhancement of the vasculature for an extended period of time. Initial excretion was primarily through the renal system. Later uptake was observed in the stomach and lower gastrointestinal tract. Macromolecular hyaluronan-based gadolinium agents have a high clinical translation potential as hyaluronan is already approved by FDA for a variety of medical applications.

Original languageEnglish (US)
Pages (from-to)61-68
Number of pages8
JournalContrast Media and Molecular Imaging
Issue number2
StatePublished - Mar 2011


  • Biocompatible contrast agents
  • Hyaluronan
  • Magnetic resonance angiography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Biocompatible blood pool MRI contrast agents based on hyaluronan'. Together they form a unique fingerprint.

Cite this